Table 5.
Prediction of FeNO reduction.
| ODD | CI | p | |
|---|---|---|---|
| Biological therapy | 1.26 | 0.39–4.03 | 0.695 |
| LTRA therapy | 4.85 | 1.09–21.51 | 0.037 |
| Unplanned visits to specialists at T1 time | 0.10 | 0.02–0.50 | 0.005 |
| ΔACT | 1.01 | 0.91–1.01 | 0.762 |
| Age | 1.01 | 0.94–1.06 | 0.948 |
| Sex | 1.65 | 0.40–6.71 | 0.481 |
ACT: asthma control test. ΔACT = ACT T1 − ACT T0. FeNO: exhaled nitric oxide. LTRA: leukotriene receptor antagonist. Probability of having a reduction in FeNO 50 in relation to the type of biological therapy. to the main confounding factors (age and sex) and to the parameters that were statistically significant for p < 0.050.